XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert S. who wrote (7775)	11/19/1998 11:54:00 PM
From: Robert K.	Read Replies (1) of 17367

I do not accept that bpi neutralizes cytokines. It attenuates certain cytokines. Which cytokines does it attenuate and what are their roles? Under what conditions? How about that tnf. In complement its numero uno in my book. Eicosanoids and kinins I have no idea, but doubt any effect. Fibrinolytic, you didnt even mention. Questions back at you. Are you aware of any product that affects more inflamatory mediators than bpi? Is bpi a defacto cocktail? If bpi ever does get to market will they test it with anti tnf monoclonals? Ha1a or e5? Hey Rick, when you get to this one why dont you throw in a comment too.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next